What is the "enterprise streamlining initiative"?

The 8-K filing does not provide specific details about the 'enterprise streamlining initiative.' However, it indicates that this initiative will result in charges affecting the company's GAAP diluted EPS from continuing operations, suggesting a focus on restructuring or cost-reduction efforts that may involve asset impairment, severance, or other one-time expenses.

How does this update affect CVS Health's earnings?

The update specifically impacts the company's reported GAAP diluted EPS from continuing operations, which will be lower due to charges from the streamlining initiative. However, the company's Adjusted EPS guidance for both 2016 and 2017 has been reaffirmed, implying that the underlying business performance, excluding these specific charges, is expected to meet previous expectations.

What is the difference between GAAP EPS and Adjusted EPS in this context?

GAAP (Generally Accepted Accounting Principles) EPS reflects the company's earnings per share according to standard accounting rules, including all expenses, even one-time or unusual ones like restructuring charges. Adjusted EPS is a non-GAAP measure that typically excludes such items, providing a view of the company's ongoing operational profitability. In this case, the streamlining charges are affecting GAAP EPS but not the reaffirmed Adjusted EPS.

Should investors be concerned about the updated guidance?

Investors should differentiate between the GAAP EPS impact and the Adjusted EPS reaffirmation. While the GAAP EPS reduction is a negative event, the reaffirmation of Adjusted EPS suggests that the core business operations are performing as expected. The impact on GAAP EPS is likely to be a one-time or short-term charge related to restructuring, rather than a fundamental decline in business performance.

CVS 8-K: Regulation FD — Dec 15, 2016

Summary

CVS Health Corporation (CVS) filed an 8-K on December 15, 2016, to disclose an update to its financial guidance. The company announced charges related to an "enterprise streamlining initiative." This initiative is expected to impact GAAP diluted EPS from continuing operations, indicating a one-time or restructuring cost that will reduce reported earnings. Despite the GAAP EPS adjustment, CVS Health reaffirmed its previous guidance for Adjusted EPS for both fiscal years 2016 and 2017. This suggests that the core operational performance of the business remains on track and is not affected by the streamlining charges. Investors should note the distinction between GAAP and Adjusted EPS, as the latter typically excludes non-recurring or extraordinary items.

Key Highlights

1CVS Health announced an "enterprise streamlining initiative" impacting its operations.
2GAAP diluted EPS guidance from continuing operations has been updated to reflect charges associated with this initiative.
3The company reaffirmed its prior Adjusted EPS guidance for both 2016 and 2017.
4The press release containing this information is attached as Exhibit 99.1 to the 8-K filing.
5The filing clarifies that the information is furnished, not filed, and will not be incorporated into future registration statements unless explicitly stated.
6This update signals potential short-term accounting impacts from restructuring, while core operational expectations remain stable based on reaffirmed Adjusted EPS.

CVS HEALTH Corp 8-K Report, Regulation FD Disclosure (Dec 15, 2016)

Summary

Key Highlights

Frequently Asked Questions